S&P Global (NYSE:SPGI) has outperformed the market over the past 5 years by 6.09% on an annualized basis producing an average annual return of 18.87%. Currently, S&P Global has a market capitalization of $136.59 billion.
Buying $100 In SPGI: If ...
S&P Global (NYSE:SPGI) has outperformed the market over the past 5 years by 6.09% on an annualized basis producing an average annual return of 18.87%. Currently, S&P Global has a market capitalization of $136.59 billion.
Buying $100 In SPGI: If ...
Market Wire News is a media platform, the information on this page was provided by Benzinga via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 10:15:02 ET BMO Capital analyst issues OUTPERFORM recommendation for SPGI on July 2, 2024 08:38AM ET. The previous analyst recommendation was Outperform. SPGI was trading at $446.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
S&P Global Schedules Second Quarter 2024 Earnings Announcement and Conference Call for Tuesday, July 30, 2024 S&P Global Schedules Second Quarter 2024 Earnings Announcement and Conference Call for Tuesday, July 30, 2024 PR Newswire NEW YORK , June 28, 202...
Protagonist Therapeutics Set to Join S&P SmallCap 600 Protagonist Therapeutics Set to Join S&P SmallCap 600 PR Newswire NEW YORK , June 27, 2024 /PRNewswire/ -- Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in ...